RxDoctor Payments Data

Timothy Rice, DO

Family Medicine · Cherokee, IANPI 1841295532

Payments from drug & device makers

$518in general payments, 2019–2025

Across 32 payments — averaging $16.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$179
  • Astellas Pharma US Inc$130
  • Amgen$54
  • Bayer$37
  • Pfizer$36
  • Baxter Healthcare$16
  • plus $65 from 6 others

What the payments were for

  • Food & beverage$41781%
  • Education$10119%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$518 in reported general payments places this provider in the 70th percentile of 1,357 family medicine providers in Iowa.

See all family medicine providers in Iowa

Medicare billing

Part B allowed, 2024
$26,156
Medicare patients
91
Services billed
298

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban116$83,240
OzempicSemaglutide68$73,261
JanuviaSitagliptin Phosphate78$39,395
JardianceEmpagliflozin37$37,078
XareltoRivaroxaban42$20,783
Breo ElliptaFluticasone/Vilanterol57$20,574
MyrbetriqMirabegron55$17,354
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog57$17,305
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr17$8,042
Trelegy ElliptaFluticasone/Umeclidin/Vilanter12$7,412
SymbicortBudesonide/Formoterol Fumarate21$6,802
Lantus SolostarInsulin Glargine,hum.Rec.Anlog48$4,728
Olanzapine11$3,193
Quetiapine Fumarate66$2,739
Fluticasone-SalmeterolFluticasone Propion/Salmeterol25$2,535

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$36$83,240116 claims
Novo NordiskOzempic$179$73,26168 claims
Boehringer IngelheimJardiance$14$37,07837 claims
GSKBreo Ellipta, Anoro Ellipta, Trelegy Ellipta$12$36,02886 claims
Astellas Pharma US IncMyrbetriq$130$17,35455 claims
AstraZenecaSymbicort$15$6,80221 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 1,357 family medicine providers in Iowa.

Other family medicine in Cherokee

See the full list for Iowa

Where these figures come from

Is this you, or does something look wrong? →